Gene · 9536
Papers2,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular mechanisms of taste disturbance induced by the non-steroidal anti-inflammatory drug, diclofenac, in mice. | Front Cell Neurosci | 2023 | 38164437 | PubTator, text mining | PubMed |
| Design and Evaluation of Synthesized Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR Approach. | ACS Omega | 2023 | 38162789 | PubTator, text mining | PubMed |
| A moderate dosage of prostaglandin E2-mediated annexin A1 upregulation promotes alkali-burned corneal repair. | iScience | 2023 | 38144456 | PubTator, text mining | PubMed |
| MeCP2-Induced Alternations of Transcript Levels and m6A Methylation in Human Retinal Pigment Epithelium Cells. | ACS Omega | 2023 | 38144074 | PubTator, text mining | PubMed |
| Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles. | Pharmaceutics | 2023 | 38140059 | PubTator, text mining | PubMed |
| Editorial: Lipidomics of oxylipins in biological systems. | Front Pharmacol | 2023 | 38125891 | PubTator, text mining | PubMed |
| Targeted therapies in bladder cancer: signaling pathways, applications, and challenges. | MedComm (2020) | 2023 | 38107059 | PubTator, text mining | PubMed |
| PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment. | Front Immunol | 2023 | 38106415 | PubTator, text mining | PubMed |
| Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma. | Front Immunol | 2023 | 38090559 | PubTator, text mining | PubMed |
| Targeting the myeloid microenvironment in neuroblastoma. | J Exp Clin Cancer Res | 2023 | 38087370 | PubTator, text mining | PubMed |
| Comparison of the Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis. | Int J Mol Sci | 2023 | 38069242 | PubTator, text mining | PubMed |
| Identification and partial characterization of new cell density-dependent nucleocytoplasmic shuttling proteins and open chromatin. | Sci Rep | 2023 | 38066085 | PubTator, text mining | PubMed |
| Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. | Mil Med Res | 2023 | 38044445 | PubTator, text mining | PubMed |
| Different PfEMP1-expressing Plasmodium falciparum variants induce divergent endothelial transcriptional responses during co-culture. | PLoS One | 2023 | 38033133 | PubTator, text mining | PubMed |
| The effect of TLR3 priming conditions on MSC immunosuppressive properties. | Stem Cell Res Ther | 2023 | 38031182 | PubTator, text mining | PubMed |
| Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy. | Front Immunol | 2023 | 38022518 | PubTator, text mining | PubMed |
| Allogenic Platelet-Rich Plasma for the Treatment of Adhesive Capsulitis. | Cureus | 2023 | 38022351 | PubTator, text mining | PubMed |
| The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential. | Expert Opin Ther Targets | 2023 | 38015194 | PubTator, text mining | PubMed |
| Role of arachidonic acid metabolism in intervertebral disc degeneration: identification of potential biomarkers and therapeutic targets via multi-omics analysis and artificial intelligence strategies. | Lipids Health Dis | 2023 | 38007425 | PubTator, text mining | PubMed |
| Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation. | Int J Mol Sci | 2023 | 38003290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9536/papers?page=8